Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report released on Tuesday. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Up 9.7 %

Shares of ENZ opened at $0.32 on Tuesday. Enzo Biochem has a 1-year low of $0.25 and a 1-year high of $1.28. The firm’s 50 day simple moving average is $0.47 and its 200 day simple moving average is $0.79.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings data on Monday, March 17th. The medical research company reported ($0.02) earnings per share for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%. The company had revenue of $7.33 million for the quarter.

Hedge Funds Weigh In On Enzo Biochem

Hedge funds and other institutional investors have recently modified their holdings of the company. Mink Brook Asset Management LLC bought a new stake in Enzo Biochem in the 4th quarter worth approximately $577,000. Lepercq Multi Asset Fund bought a new stake in shares of Enzo Biochem in the 4th quarter worth approximately $88,000. Wittenberg Investment Management Inc. boosted its stake in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after purchasing an additional 70,400 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Enzo Biochem during the 4th quarter valued at $35,000. Finally, Geode Capital Management LLC raised its position in Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the period. 36.90% of the stock is currently owned by hedge funds and other institutional investors.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.